z-logo
open-access-imgOpen Access
Beyond conventional secondary prevention in coronary artery disease—what to choose in the era of CANTOS, COMPASS, FOURIER, ODYSSEY and PEGASUS-TIMI 54? A review on contemporary literature
Author(s) -
Daniel Kalbacher,
Christoph Waldeyer,
Stefan Blankenberg,
Dirk Westermann
Publication year - 2018
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.08.03
Subject(s) - medicine , coronary artery disease , intensive care medicine , residual risk , disease , randomized controlled trial , cardiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom